IL140334A - Use of an activated carbon filter as an oxidation inhibitor for prostane derivatives and processes for manufacturing pharmaceutical compositions - Google Patents

Use of an activated carbon filter as an oxidation inhibitor for prostane derivatives and processes for manufacturing pharmaceutical compositions

Info

Publication number
IL140334A
IL140334A IL14033499A IL14033499A IL140334A IL 140334 A IL140334 A IL 140334A IL 14033499 A IL14033499 A IL 14033499A IL 14033499 A IL14033499 A IL 14033499A IL 140334 A IL140334 A IL 140334A
Authority
IL
Israel
Prior art keywords
oxidation inhibitor
processes
pharmaceutical compositions
activated carbon
carbon filter
Prior art date
Application number
IL14033499A
Other languages
English (en)
Other versions
IL140334A0 (en
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of IL140334A0 publication Critical patent/IL140334A0/xx
Publication of IL140334A publication Critical patent/IL140334A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/557Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/558Eicosanoids, e.g. leukotrienes or prostaglandins having heterocyclic rings containing oxygen as the only ring hetero atom, e.g. thromboxanes
    • A61K31/5585Eicosanoids, e.g. leukotrienes or prostaglandins having heterocyclic rings containing oxygen as the only ring hetero atom, e.g. thromboxanes having five-membered rings containing oxygen as the only ring hetero atom, e.g. prostacyclin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/557Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682Processes
    • A61K9/1694Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
    • C08B37/0012Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof
    • C08B37/0015Inclusion compounds, i.e. host-guest compounds, e.g. polyrotaxanes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Materials Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Biochemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Anti-Oxidant Or Stabilizer Compositions (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
IL14033499A 1998-06-22 1999-06-22 Use of an activated carbon filter as an oxidation inhibitor for prostane derivatives and processes for manufacturing pharmaceutical compositions IL140334A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19828881A DE19828881A1 (de) 1998-06-22 1998-06-22 Oxidationsinhibitor bei Prostan-Derivaten
PCT/EP1999/004278 WO1999067212A2 (de) 1998-06-22 1999-06-22 Aktivkohlefilter als oxidationsinhibitor bei protan-derivaten

Publications (2)

Publication Number Publication Date
IL140334A0 IL140334A0 (en) 2002-02-10
IL140334A true IL140334A (en) 2005-12-18

Family

ID=7872332

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14033499A IL140334A (en) 1998-06-22 1999-06-22 Use of an activated carbon filter as an oxidation inhibitor for prostane derivatives and processes for manufacturing pharmaceutical compositions

Country Status (19)

Country Link
US (1) US6512139B1 (cs)
EP (1) EP1089970B1 (cs)
JP (1) JP2002518475A (cs)
KR (1) KR100689143B1 (cs)
AT (1) ATE263757T1 (cs)
AU (1) AU763442B2 (cs)
CA (1) CA2335781A1 (cs)
CZ (1) CZ301018B6 (cs)
DE (2) DE19828881A1 (cs)
DK (1) DK1089970T3 (cs)
ES (1) ES2219043T3 (cs)
HU (1) HUP0102870A3 (cs)
IL (1) IL140334A (cs)
NO (1) NO327048B1 (cs)
PL (1) PL193957B1 (cs)
PT (1) PT1089970E (cs)
RU (1) RU2226525C2 (cs)
SK (1) SK286011B6 (cs)
WO (1) WO1999067212A2 (cs)

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4054736A (en) * 1970-06-10 1977-10-18 Ono Pharmaceutical Co., Ltd. Clathrate compounds of prostaglandins or their analogues with cyclodextrin
JPS503362B1 (cs) * 1970-06-10 1975-02-04
DE2845770A1 (de) * 1978-10-19 1980-04-30 Schering Ag Neue prostacyclin-derivate und verfahren zu ihrer herstellung
JPS56150039A (en) * 1980-04-22 1981-11-20 Sankyo Co Ltd Clathrate compound of prostacycline derivative
DE3048906A1 (de) * 1980-12-19 1982-07-15 Schering Ag, 1000 Berlin Und 4619 Bergkamen Neue carbacycline, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE3608088C2 (de) * 1986-03-07 1995-11-16 Schering Ag Pharmazeutische Präparate, enthaltend Cyclodextrinclathrate von Carbacyclinderivaten
DE3708537A1 (de) * 1987-03-13 1988-09-22 Schering Ag 6-oxoprostaglandin-e-derivate, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung
DE3816801A1 (de) * 1988-05-13 1989-11-23 Schering Ag Verfahren zur herstellung von carbacyclinen
JPH03220201A (ja) 1988-11-18 1991-09-27 Eisai Co Ltd プロスタグランジン類と多糖類の結合体
EP0686036B1 (de) * 1992-08-07 1997-03-12 Schering Aktiengesellschaft Verwendung von prostanderivaten zur herstellung eines arzneimittels zur behandlung der chronischen polyarthritis
AU5376994A (en) * 1992-11-10 1994-06-08 Nippon Shinyaku Co. Ltd. Enclosure compound manufacturing method
JP2677779B2 (ja) * 1996-06-28 1997-11-17 三共株式会社 プロスタグランジン類
DE19739693A1 (de) * 1997-09-04 1999-03-11 Schering Ag Pharmazeutische Präparate zur Behandlung der Multiplen Sklerose
DE19808634A1 (de) 1998-02-24 1999-08-26 Schering Ag Mantel für eine pharmazeutische Zusammensetzung
JPH11322612A (ja) * 1998-03-13 1999-11-24 Toray Ind Inc 肝細胞増殖因子誘引剤

Also Published As

Publication number Publication date
DE59909125D1 (de) 2004-05-13
CA2335781A1 (en) 1999-12-29
US6512139B1 (en) 2003-01-28
DK1089970T3 (da) 2004-08-02
NO327048B1 (no) 2009-04-14
KR20010053075A (ko) 2001-06-25
DE19828881A1 (de) 1999-12-23
EP1089970A2 (de) 2001-04-11
NO20006578D0 (no) 2000-12-21
PT1089970E (pt) 2004-08-31
AU763442B2 (en) 2003-07-24
CZ301018B6 (cs) 2009-10-14
CZ20004791A3 (cs) 2001-04-11
KR100689143B1 (ko) 2007-03-08
WO1999067212A3 (de) 2000-03-30
RU2226525C2 (ru) 2004-04-10
JP2002518475A (ja) 2002-06-25
SK286011B6 (sk) 2008-01-07
HUP0102870A2 (hu) 2001-12-28
PL193957B1 (pl) 2007-04-30
AU5279899A (en) 2000-01-10
EP1089970B1 (de) 2004-04-07
NO20006578L (no) 2000-12-21
ES2219043T3 (es) 2004-11-16
HUP0102870A3 (en) 2002-12-28
ATE263757T1 (de) 2004-04-15
SK19362000A3 (sk) 2001-05-10
IL140334A0 (en) 2002-02-10
PL345288A1 (en) 2001-12-03
WO1999067212A2 (de) 1999-12-29

Similar Documents

Publication Publication Date Title
WO2009041049A1 (ja) 殺菌方法および装置
DK0603329T3 (da) Fremgangsmåde og sammensætning til behandling af råmaterialer, produkter og produktionsmidler, især i næringsmiddelindustrien.
US4368081A (en) Method for removing residual hydrogen peroxide on a sterilized food package
CA2312652A1 (en) Reduction of toxic substances in waste gas emissions
CA2317328A1 (en) Freshness-retaining agent and method for agricultural/horticultural products
MA27051A1 (fr) Composition solide contenant des spores de bacteries non pathogenes du genre bacillus
CN108057328A (zh) 去除室内空气中甲醛的净化剂及其制备方法
DE69301778D1 (de) Verfahren zur Reinigung wässriger Alkalimetallchloridlösung zur Entfernung von Iod
IL140334A (en) Use of an activated carbon filter as an oxidation inhibitor for prostane derivatives and processes for manufacturing pharmaceutical compositions
CA2081730A1 (fr) Procede d'epuration de liquides aqueux a l'aide d'un agent d'epuration constitue de poudre de charbon actif sous enveloppe d'alcool polyvinylique et agent d'epuration correspondant
EP1236497A3 (en) Exhaust gas processing system
HUP0002119A2 (hu) Eljárás nehézfémek eltávolítására
SU718072A1 (ru) Способ детоксикации зерна,пораженного микрофлорой и ее токсинами
SE0201891L (sv) Avlägsnande av vattenlösliga föreningar ur träflis före kokningen
AU2001281808A1 (en) Method for impregnating an object or substance with a solution containing an oxidating agent
EP1090673A3 (en) Treatment of gas mixtures
ES2078742T3 (es) Procedimiento para la eliminacion de oxido de etileno gaseoso.
DE50009238D1 (de) Verfahren zur minderung des gehalts von polychlorierten dibenzodioxinen und -furanen im abgas von chemischen hochtemperatur-prozessen
KR20000062049A (ko) 숯을 이용한 장류제품(된장과 그외 장류)
UA21941C2 (uk) Спосіб розкладу закису азоту
KR20000062047A (ko) 숯을 이용한 인스탄트 면들과 국수와 그외 면류
KR20000061991A (ko) 숯을 이용한 낙농유제품
WO2000038662A3 (en) The manipulation of the activity of a nitric oxide radical production pathway for the treatment of diseases associated with the presence of oxygen free radicals
UA32228A (uk) Спосіб очищення стічних вод від сполук хрому
DE59801253D1 (de) Verfahren zum Reinigen von Gasen

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees